ALB and neoplasm: Moreover, nanoparticulate albumin DDS have been established in the form of nanoparticle albumin bound (nab)-paclitaxel, which uses nanoparticles as a carrier for paclitaxel and can thus achieve higher accumulation in tumor tissue as well as reduced systemic toxicity [44,45,46].